Self-Medication with Antibiotics Among Out-Patient Attendants Prior to Medical Consultation at A Tertiary Care Hospital - A Cross-Sectional Study

Autor: Ashok Umayorubhagom, Gayathri G Nair, Ooviya Jayaseelan, Sulakshana S Baliga

Publikováno v: National Journal of Community Medicine, Vol 15, Iss 09 (2024)

Introduction: One of the greatest threats to global development and public health is antimicrobial resistance (AMR). The ability of bacteria and other microbes to resist the drugs used to inactivate them is known as AMR. According to estimates, bacte

Externí odkaz: https://doaj.org/article/11287e946b3749f589732c7acfa358e2

HMB-45 Negative Adrenal Angiomyolipoma With A Synchronous Adrenal Adenoma – An Unusual Association

Autor: Vijayalakshmi Nair, Sreeja Raju, Joy Augustine, Gayathri G Nair

Publikováno v: Annals of Pathology and Laboratory Medicine. 7:C99-102

Background: Angiomyolipoma (AML) is an uncommon mesenchymal tumour usually found in the kidney. The most common extrarenal site is usually the liver. We report a case of adrenal AML with a predominant vascular component co-existing with an adrenal ad

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d5749c26b7f2f030fcb9619cde493e4a
https://doi.org/10.21276/apalm.2826

Langerhans cell histiocytosis presenting as isolated central diabetes insipidus in a 2-year-old child: a rare manifestation of rare disease

Autor: Sri Lakshmi Chordia, Arulkumaran Arunagirinathan, S R Nirmal, Gayathri G. Nair, Revathi Krishnakumar

Publikováno v: International Journal of Contemporary Pediatrics. 6:1386

Central diabetes insipidus, though uncommon in children, has varied causes, the commonest ones being genetic mutations, infiltrative disorders, infections. Isolated central diabetes insipidus is not one of the often encountered conditions in the pedi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7e1d5f60ab91597c40fbd651c7cd2d31
https://doi.org/10.18203/2349-3291.ijcp20192050

The role of registries in hematological disorders.

Autor: Baldomero H; Worldwide Network of Blood and Marrow Transplantation (WBMT) Transplant Activity Survey Office, University Hospital, Basel, CH, UK., Neumann D; Institute of Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., Hamad N; Haematology Clinical Research Unit, St. Vincent's Health Network, Kinghorn Cancer Centre, Sydney, Australia; Department of Haematology, St Vincent's Hospital Sydney, Australia; School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Australia; School of Medicine, Sydney, Australia; University of Notre Dame Australia, Australia., Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan., Sureda A; Clinical Hematology Department, Institut Català d'Oncologia - L'Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Iida M; Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute, Japan., Karduss A; Instituto de Cancerología-Clínica Las Américas, Medellín, Colombia., Elhaddad AM; Department of Pediatric Oncology and Stem Cell Transplantation Unit, Cairo University Cairo, Egypt., Bazuaye NG; Department of Hematology and Blood Transfusion, University of Benin Teaching Hospital, Edo State, Nigeria., Bonfim C; Pele Pequeno Principe Research Institute/ Pediatric Blood and Marrow Transplantation Program Hospital Pequeno Principe, Curitiba, Brazil., Camara R; Hematology Department, Hospital de la Princesa, Madrid, Spain., Chaudhri NA; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia., Ciceri F; Ospedale San Raffaele s.r.l., Haematology and BMT, Milano, Italy., Correa C; Hospital Israelita Albert Einstein, Sao Paula Brazil., Frutos C; Instituto de Previsión Social, Asunción, Paraguay., Galeano S; Hospital Británico, Montevideo, Uruguay., Garderet L; Sorbonne Université, Service d'Hématologie et Thérapie Cellulaire, HôpitalPitié Salpêtrière, AP-HP, Paris, France., Greco R; Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy., Jaimovich G; Hospital Universitario Fundacion Favaloro, Buenos Aires, Argentina., Kodera Y; Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute, Japan., Koh MB; Institute for Infection and Immunity St. George's Hospital and Medical School, University of London, London, UK., Liu K; Department of Hematology, Peking University Institute of Hematology, Beijing, China., Ljungman P; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital Huddinge, Stockholm, Sweden., McLornan DP; Department of Haematology, University College Hospital, London, UK., Nair G; Blutspende SRK Schweiz AG, UK., Okamoto S; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan., Pasquini MC; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA., Passweg J; The Worldwide Network of Blood and Marrow Transplantation (WBMT) Transplant Activity Survey Office, University Hospital, Basel, Switzerland., Paulson K; Section of Haematology/Oncology, Department of Internal Medicine, Max Rady College of Medicine, The University of Manitoba, Winnipeg, Manitoba, Canada., Ruggeri A; Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy., Seber A; Hospital Samaritano Higienópolis & Graacc-- Universidade Federal de Sao Paulo, Sao Paulo, Brazil., Snowden JA; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Srivastava A; Department of Hematology, Christian Medical College Hospital, Vellore, India., Worel N; Department of Transfusion Medicine and Cell Therapy, Medical University of Vienna, Vienna, Austria., Saber W; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital Huddinge, Stockholm, Sweden., Rondelli D; Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL, USA., Aljurf M; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia., Niederwieser D; University of Leipzig, Leipzig, Germany; Aichi Medical University School of Medicine, Nagakute, Japan; Lithuanian University of Health Sciences, Kaunas, Lithuania. Electronic address: dietger@medizin.uni-leipzig.de.

Publikováno v: Best practice & research. Clinical haematology [Best Pract Res Clin Haematol] 2024 Jun; Vol. 37 (2), pp. 101556. Date of Electronic Publication: 2024 Jul 05.

Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT.

Autor: Ben Hassine K; Department of Pediatrics, Gynecology and Obstetrics, Cansearch Research Platform for Pediatric Oncology and Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Seydoux C; Division of Hematology, University Hospital of Basel, Basel, Switzerland., Khier S; Pharmacokinetic and Modeling Department, School of Pharmacy, Montpellier University, Montpellier, France; Probabilities and Statistics Department, Institut Montpelliérain Alexander Grothendieck (IMAG), CNRS, UMR 5149, Inria, Montpellier University, Montpellier, France., Daali Y; Division of Clinical Pharmacology and Toxicology, University Hospital of Geneva, Geneva, Switzerland; Faculty of Medicine & Sciences, University of Geneva, Geneva, Switzerland., Medinger M; Division of Hematology, University Hospital of Basel, Basel, Switzerland and University Basel, Basel, Switzerland., Halter J; Division of Hematology, University Hospital of Basel, Basel, Switzerland and University Basel, Basel, Switzerland., Heim D; Division of Hematology, University Hospital of Basel, Basel, Switzerland and University Basel, Basel, Switzerland., Chalandon Y; Division of Hematology, Bone Marrow Transplant Unit, University Hospital of Geneva and Faculty of Medicine, University of Geneva, Geneva, Switzerland., Schanz U; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland., Nair G; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland., Cantoni N; Division of Oncology, Hematology and Transfusion Medicine, Kantonsspital Aarau, Aarau, Switzerland., Passweg JR; Division of Hematology, University Hospital of Basel, Basel, Switzerland and University Basel, Basel, Switzerland., Satyanarayana Uppugunduri CR; Department of Pediatrics, Gynecology and Obstetrics, Cansearch Research Platform for Pediatric Oncology and Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Ansari M; Department of Pediatrics, Gynecology and Obstetrics, Cansearch Research Platform for Pediatric Oncology and Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Division of Pediatric Oncology and Hematology, Department of Women, Child and Adolescent, University Geneva Hospitals, Geneva, Switzerland. Electronic address: Marc.Ansari@hcuge.ch.

Publikováno v: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar; Vol. 30 (3), pp. 332.e1-332.e15. Date of Electronic Publication: 2023 Dec 09.